These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17515292)

  • 1. In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443).
    Uckun FM; Tibbles H; Erbeck D; Venkatachalam TK; Qazi S
    Arzneimittelforschung; 2007; 57(4):218-26. PubMed ID: 17515292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved oral bioavailability of anti-HIV agent N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443) in a novel lipophilic formulation.
    Uckun FM; Erbeck D; Tibbles H; Qazi S; Venkatachalam TK
    Arzneimittelforschung; 2007; 57(3):164-70. PubMed ID: 17469651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo pharmacokinetics, metabolism, toxicity, and anti-HIV activity of N'-[2-(2-Thiophene)ethyl]-N'-[2-(5-bromopyridyl)]thiourea (HI-443), a potent non-nucleoside inhibitor of HIV reverse transcriptase.
    Uckun FM; Tibbles HE; Venkatachalam TK; Erbeck D
    Arzneimittelforschung; 2007; 57(7):483-96. PubMed ID: 17803063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo toxicity, pharmacokinetic features and tissue distribution of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236), a potent non-nucleoside inhibitor of HIV-1 reverse transcriptase.
    Chen CL; Venkatachalam TK; Waurzyniak B; Chelstrom L; Uckun FM
    Arzneimittelforschung; 2001; 51(7):574-81. PubMed ID: 11505789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale synthesis of GMP grade N'- [2-(2-thiophene) ethyl]-N'- [2- (5-bromopyridyl)] -thiourea (HI-443), a new anti-HIV drug candidate.
    DuMez D; Venkatachalam TK; Uckun FM
    Arzneimittelforschung; 2007; 57(6):330-8. PubMed ID: 17688078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel vaginal microbicide containing the rationally designed anti-HIV compound HI-443 (N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea]).
    D'Cruz OJ; Qazi S; Yiv S; Uckun FM
    Expert Opin Investig Drugs; 2012 Mar; 21(3):265-79. PubMed ID: 22292483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N'-[2-(2-thiophene) ethyl]-N'-[2-(5-bromopyridyl)]thiourea (HI-443), a rationally designed non-nucleoside reverse transcriptase inhibitor compound with potent anti-HIV activity.
    Uckun FM; Qazi S; Venkatachalam T
    Arzneimittelforschung; 2007; 57(5):278-85. PubMed ID: 17598700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the pharmacokinetic features and tissue distribution of the potent nonnucleoside inhibitor of HIV-1 reverse transcriptase, N-[2-(2-fluorophenethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-240) with an analytical HPLC method.
    Chen CL; Uckun FM
    Pharm Res; 1999 Aug; 16(8):1226-32. PubMed ID: 10468024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency virus-1.
    Uckun FM; Pendergrass S; Maher D; Zhu D; Tuel-Ahlgren L; Mao C; Venkatachalam TK
    Bioorg Med Chem Lett; 1999 Dec; 9(24):3411-6. PubMed ID: 10617082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea and N'-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1.
    Uckun FM; Mao C; Pendergrass S; Maher D; Zhu D; Tuel-Ahlgren L; Venkatachalam TK
    Bioorg Med Chem Lett; 1999 Sep; 9(18):2721-6. PubMed ID: 10509923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 13-week subchronic intravaginal toxicity study of the novel broad-spectrum anti-HIV and spermicidal agent, N-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (PHI-346) in mice.
    D'Cruz OJ; Waurzyniak B; Uckun FM
    Toxicol Pathol; 2002; 30(6):687-95. PubMed ID: 12512870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-[2-(4-methylphenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea as a potent inhibitor of NNRTI-resistant and multidrug-resistant human immunodeficiency virus type 1.
    Uckun FM; Mao C; Pendergrass S; Maher D; Zhu D; Tuel-Ahlgren L; Venkatachalam TK
    Antivir Chem Chemother; 2000 Mar; 11(2):135-40. PubMed ID: 10819437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperidinylethyl, phenoxyethyl and fluoroethyl bromopyridyl thiourea compounds with potent anti-HIV activity.
    Venkatachalam TK; Sudbec EA; Mao C; Uckun FM
    Antivir Chem Chemother; 2000 Sep; 11(5):329-36. PubMed ID: 11142631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236) as a potent broad-spectrum anti-human immunodeficiency virus microbicide.
    D'Cruz OJ; Uckun FM
    Mol Hum Reprod; 2005 Oct; 11(10):767-77. PubMed ID: 16254003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus.
    Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM
    Bioorg Med Chem Lett; 1999 Jun; 9(11):1593-8. PubMed ID: 10386942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PHI-443: a novel noncontraceptive broad-spectrum anti-human immunodeficiency virus microbicide.
    D'Cruz OJ; Samuel P; Uckun FM
    Biol Reprod; 2004 Dec; 71(6):2037-47. PubMed ID: 15306558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor of HIV-1 reverse transcriptase: N'-(5-bromo-2-pyridyl)-N-[2-(2,5-dimethoxyphenyl)ethyl]thiourea.
    Sudbeck EA; Jennissen JD; Venkatachalam TK; Uckun FM
    Acta Crystallogr C; 1999 Dec; 55 ( Pt 12)():2122-4. PubMed ID: 10641283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [d4U]-butyne-[HI-236] as a non-cleavable, bifunctional NRTI/NNRTI HIV-1 reverse-transcriptase inhibitor.
    Hunter R; Muhanji CI; Hale I; Bailey CM; Basavapathruni A; Anderson KS
    Bioorg Med Chem Lett; 2007 May; 17(9):2614-7. PubMed ID: 17317163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative cytotoxicity of N-substituted N'-(4-imidazole-ethyl)thiourea in precision-cut rat liver slices.
    Onderwater RC; Commandeur JN; Vermeulen NP
    Toxicology; 2004 Apr; 197(2):81-91. PubMed ID: 15003319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel thiourea compounds as dual-function microbicides.
    D'Cruz OJ; Venkatachalam TK; Uckun FM
    Biol Reprod; 2000 Jul; 63(1):196-205. PubMed ID: 10859260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.